Wolverine Trading, LLC Crispr Therapeutics Ag Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

A detailed history of Wolverine Trading, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wolverine Trading, LLC holds 17,479 shares of CRSP stock, worth $870,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,479

Previous 29,487 40.72%

Holding current value

$870,279

Previous $2.01 Million 53.01%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $614,449 - $818,705	-12,008 Reduced 40.72%	17,479 $944,000
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $580,247 - $852,343	9,564 Added 48.0%	29,487 $2.01 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $33,329 - $62,291	863 Added 4.53%	19,923 $1.25 Million
Q3 2023 Nov 15, 2023	BUY	$45.39 - $59.0 $229,628 - $298,481	5,059 Added 36.13%	19,060 $865,000
Q2 2023 Aug 23, 2023	BUY	$43.47 - $67.77 $411,226 - $641,104	9,460 Added 208.32%	14,001 $786,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $36,285 - $49,666	-885 Reduced 16.31%	4,541 $201,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $68,739 - $115,185	1,754 Added 47.77%	5,426 $221,000
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $191,854 - $263,069	-3,140 Reduced 46.1%	3,672 $237,000
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $701,363 - $1.2 Million	-16,224 Reduced 70.43%	6,812 $429,000
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $859,018 - $1.28 Million	-16,150 Reduced 41.21%	23,036 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $410,587 - $651,936	5,858 Added 17.58%	39,186 $3.09 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1.82 Million - $2.58 Million	-16,474 Reduced 33.08%	33,328 $3.67 Million
Q2 2021 Aug 06, 2021	SELL	$100.84 - $161.89 $1.2 Million - $1.93 Million	-11,949 Reduced 19.35%	49,802 $7.5 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $3.05 Million - $5.78 Million	27,504 Added 80.31%	61,751 $7.11 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $1.47 Million - $3.21 Million	18,512 Added 117.65%	34,247 $5.53 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $488,348 - $626,081	-6,221 Reduced 28.33%	15,735 $1.34 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $176,445 - $348,537	4,583 Added 26.38%	21,956 $1.65 Million
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $128,522 - $238,614	3,816 Added 28.15%	17,373 $769,000
Q4 2019 Feb 12, 2020	SELL	$36.68 - $73.13 $110,553 - $220,413	-3,014 Reduced 18.19%	13,557 $838,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $734,923 - $1.09 Million	16,571 New	16,571 $735,000

Others Institutions Holding CRSP

# of Institutions

500

Shares Held

57M

Call Options Held

1.71M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Crispr Therapeutics Ag Transaction History